What is Laxai Pharma, Ltd. (LAXAF)?

Laxai Pharma, Ltd. (LAXAF) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is the current price of LAXAF?

The current price of LAXAF is $0.00. Prices are updated in real time on Stocks360.

What is LAXAF's market capitalization?

LAXAF's market capitalization is $475,341.00, placing it in the small-cap tier.

Laxai Pharma, Ltd. (LAXAF)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

$0.00

Market Cap

$475.34K

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

2.45

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

250.00

Laxai Pharma, Ltd. (LAXAF) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $475.34K. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Dec 27, 1994

EPS $0.04 vs est. $0.20

Missed by $0.16

Proprietary Signals

Signal snapshot temporarily unavailable.

About Laxai Pharma, Ltd.

Laxai Pharma, Ltd. is an American company that offers specialized contract research services. The firm provides extensive support throughout the entire pharmaceutical development process. Its areas of expertise include biostatistics, various data management methodologies (such as electronic, hybrid, and paper-based systems), CDISC advisory, medical documentation, clinical trial monitoring, regulatory compliance, pharmacovigilance, and associated training initiatives. The company, which was initially named Nexgen Biofuels Ltd., officially adopted the name Laxai Pharma, Ltd. in February 2010. Its headquarters are located in Tampa, Florida.